Difference between revisions of "Part:BBa K323132:Experience"
Line 47: | Line 47: | ||
[[Image:Sloviolaceingraph.JPG|left|thumb|300px| '''Figure: Violacein concentrations measured at various times through the experiment.''' The results above show that cultures containing the DNA program produce violacein more efficiently.]] | [[Image:Sloviolaceingraph.JPG|left|thumb|300px| '''Figure: Violacein concentrations measured at various times through the experiment.''' The results above show that cultures containing the DNA program produce violacein more efficiently.]] | ||
− | [[Image:Sloviolaceinhistogram.JPG|right|thumb| | + | [[Image:Sloviolaceinhistogram.JPG|right|thumb|280px| '''Figure: Violacein concentrations at the end of the experiment.''' The production of violacein was increased 6-fold in comparison with the culture without a DNA program.]] |
Revision as of 14:16, 27 October 2010
Cells containing parts with Part:BBa_K323135 and Part:BBa_K323132 were transformed with Part:BBa_K323066 or Part:BBa_K323153 or a commercial pBluescript plasmid without a DNA program. Cultures were incubated at 30°C for several days and samples were taken at various times. Violacein was extraced from individual samples to analyze the products and evaluate the yield of violacein production.
By measuring the concentrations of violacein in the extracts of taken samples, we determined that yield of violacein production in our system increased 6-fold in comparison to an E. coli strain containing a plasmid without a DNA program.
In addition, the 2010 iGEM team Slovenia have shown that a DNA program-mediated biosynthesis decreases formation of an unwanted side product deoxychromoviridans. We have analysed the products of the vio operon (Part:Bba_K274002) with HPLC, TLC and mass spectrometry (for detailed description see the 2010 iGEM team Slovenia [http://2010.igem.org/Team:Slovenia/METHODS_and_PARTS wiki]).
Applications of BBa_K323132
User Reviews
UNIQ8395d4bab017035e-partinfo-00000000-QINU UNIQ8395d4bab017035e-partinfo-00000001-QINU